James V Caruso - 02 Jul 2025 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role: Chief Executive Officer, Director
Signature: /s/ Christina Blakley, attorney-in-fact for James V. Caruso
Issuer symbol: CLRB
Transactions as of: 02 Jul 2025
Net transactions value: +$50,000
Form type: 4
Filing time: 03 Jul 2025, 08:02:08 UTC
Previous filing: 18 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
CARUSO JAMES V	Chief Executive Officer, Director	C/O CELLECTAR BIOSCIENCES, INC., 100 CAMPUS DRIVE, FLORHAM PARK	/s/ Christina Blakley, attorney-in-fact for James V. Caruso	03 Jul 2025	0001202770

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLRB	Common Stock	Purchase	$49,900	+10,000	+611%	$4.99	11,638	02 Jul 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLRB	Warrants	Purchase	$100	+10,000		$0.0100	10,000	02 Jul 2025	Common Stock	10,000	$5.25	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025.